Loading...
First Round of Abstract Submission Ends: Dec 28, 2023
Extended Early Bird Ends: Apr 16, 2024

Programme Overview

Plenary Talks

Paul Peter Tak, President, CEO, and Board Director Candel Therapeutics (Needham, MA), USA

Viral immunotherapy: A new therapeutic strategy to induce systemic anti-tumor immunity

 
Dmitry Gabrilovich, Executive Director and Chief Scientist, Cancer Immunology AstraZeneca, UK

Myeloid cells as regulators of tumor progression and effects of cancer immunotherapy

 
Zhinan Yin, National Changjian Scholar Jinan University, China

New Immune cell therapy platform:  allogenic gamma delta T cells

 
Tatsuo Kawai, A. Benedict Cosimi Chair in Transplant Surgery Harvard Medical School, USA

Clinical Transplantation Tolerance: Changing Paradigm in Organ Transplantation

 
Ofer Mandelboim, The Hebrew University Hadassha Medical School, Israel

Activation of inhibitory receptors by pathoges and tumors

 

Keynote Talks

Vimolmas Tansathitaya, Mahidol University, Thailand

Does the physical exercise affect miRNAs regulation in cancer tumor immune mechanism?

 
Ruxandra F. Sirbulescu, Harvard Medical School, USA

Immunomodulatory therapies for traumatic brain injury

 
Inpyo choi,CSO, Ingenium Therapeutics, Republic of Korea

Harnessing memory NK cells (IGNK001) for refractory acute myeloid leukemia therapy

 
Maria Francisca Palomares Jerez,University of Sevilla, Spain

Inhibition of NFᴋB and MAPK Kinanes in the Regulatory Response induced by Sulforaphane on Human Dendritic Cells

 
Aletta Petronella Susarah Terblanche,Afrigen Biologics CEO, South Africa

mRNA vaccine innovation: potential contribution to global burden of disease immunization programmes

 
Stephen Todryk,Northumbria University, Newcastle upon Tyne, UK

Antiviral immunity revealed by B cell ImmunoSpot is informative for immunity to future viral exposures

 
Mira Barda-saad, Bar-Ilan University, Isarel

Profiling Natural Killer Cell Dysfunction to Restore Anti-tumor Response, Implications for Next-Generation Immunotherapy

 

Invited Talks

Yingzi Ming,Transplantation Center, The Third Xiangya Hospital, Central South University, China

Cxcr6 recruits Th2 cells and promote schistosome-associated liver fibrosis

 
Liu Jian Jane,Englishtown, New Jersey, United States

Immunogenicity Assessment for Therapeutic Protein Products from an Industry Perspective

 
Francisco Jose Garcia Cozar,University of Cádiz, Spain

CAR-T cells beyond killing tumors

 
Xingguo She,Transplantation Center, The Third Xiangya Hospital, Central South University, China

The development and validation of predictive models for peripheral blood lymphocyte subpopulations after renal transplantation using machine learning techniques

 
Matthijs Moerland,Transplantation Center, The Third Xiangya Hospital, Central South University, China

The controlled induction of dermal innate immune responses (TLR4, TLR7)

 
Rini chaturvedi,International Centre for Genetic Engineering and Biotechnology, India

Profile of host immunological responses in malaria(TLR4, TLR7)

 
Panayiotis Vlachoyiannopoulos,University of Athens, Greece

Antiphospholipid antibodies induce proinflammatory and procoagulant pathways in endothelial cells

 
Yujun Zhao,Transplantation Center, The Third Xiangya Hospital, Central South University, China

CAV1-eNOS pathway-mediated liver sinusoidal endothelial cells impaired leads to inflammatory progression in acute-on-chronic liver failure

 
Elizabeth Hawkins, Institute of Cancer Research, UK

Armoured CAR-T Therapy to Modulate the Immune Microenvironment in Mesothelioma

 
Margaret DiGuardo, Mayo Clinic, USA

To be Confirmed

 
Stav Rabani, Weizmann Institute of Science, Isarel

CD84 as a therapeutic target for breaking immune-tolerance in triple-negative breast cancer

 
Alejandra Reyes Ruiz, Sorbonne Université, France

Induction of neonatal Fc receptor-mediated tolerance to therapeutic factor VIII in Hemophilia A

 
Nir Ben Chetrit, Weill Cornell Medicine, USA

Untangling the spatial interactions that regulate macrophage accumulation in mammary tumors

 
Lazaros Sakkas, University Of Thessaly, Greece

The T and B cells in the pathogenesis of Systemic Sclerosis

 
Francisco Jose Garcia Cozar, University of Barcelona, Spain

CAR-T cells beyond killing tumors

 
Jian Liu, Dongcheng District, Beijing, China

Immunogenicity Assessment for Therapeutic Protein Products from an Industry Perspective

 
Rini Chaturvedi, International Centre for Genetic Engineering and Biotechnology, India

Profile of host immunological responses in malaria

 
Panayiotis Vlachoyiannopoulos, Clinical and Laboratory Medicine, Greece

Antiphospholipid antibodies induce proinflammatory and procoagulant pathways in endothelial cells

 
Ting Fan Leung, The Chinese University of Hong Kong, Hongkong

Immunology and diagnosis of food allergy

 

Posters

Vera Sau Fong Chan, The University of Hong Kong, Hong Kong

PE-PPE proteins: potential TB subunit vaccine candidates

 
Benjamin Nguyen,Johns Hopkins Bloomberg School of Public Health, US

Distinct roles for interferon-α and interferon-β in recovery from Sindbis virus encephalomyelitis

 
Mojca Pavlin,University of Ljubljana, Slovenia

Will be updated soon

 
Voronov Elena, Ben Gurion University of the Negev, Isarel

Intra-cellular IL-1 alpha dictates breast cancer development and invasiveness

 
Nam Hoon Cho, Yonsei Univ Coll Med, Korea

To be confirmed

 
Prof. Hee Jung An, CHA Bundang Medical Center, Korea

To be Confirmed